SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvoke Plc Regulatory News (EVOK)

Share Price Information for Evoke Plc (EVOK)

Share Price is delayed by 15 minutes
Get Live Data
46.20    -0.55 (-1.18%)
Bid:
46.30
Ask:
46.50
Spread: 0.20 (0.432%)
Market Cap: £207.96m
EVOK Live PriceLast checked at - London Stock Exchange

Intraday Evoke Plc Share Chart

Strategic Review

10 Dec 2025 10:53

RNS Number : 0271L
Evoke PLC
10 December 2025
 

 

10 December 2025

 

For immediate release

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

evoke Plc

("evoke", the "Company", or the "Group")

 

Strategic Review

Further to the Company's announcement on 26 November 2026, and following recent media speculation, the board of directors of the Company confirms it has decided to undertake a review of the Company's strategic options, which will include the consideration of a range of potential alternatives to maximise shareholder value, including, but not limited to a potential sale of the Group, or some of the Company's assets and/or business units.

The board has appointed Morgan Stanley & Co. International plc and Rothschild & Co as its joint financial advisers in connection with the strategic review.

Shareholders are advised that there is no certainty that any transaction will materialise, nor as to the terms of any transaction.

Further announcements will be made when and if appropriate.

 

Enquiries and further information:

evoke Plc

+44(0) 800 029 3050

Per Widerström, CEO

Sean Wilkins, CFO

Elizabeth Bisby, Company Secretary

 

Investor Relations

James Finney, Director of IR

 

Morgan Stanley & Co. International plc(joint financial adviser)

 

ir@evokeplc.com

 

 

+44(0)20 7425 8000

Ben Grindley

Paolo Della Rovere 

N.M. Rothschild & Sons Limited ("Rothschild & Co") (joint financial adviser)

+44(0)20 7280 5000

Daniel Ross

Edward Duckett

 

Hudson Sandler

(public relations)

Alex Brennan

Hattie Dreyfus

+44(0)20 7796 4133

Evoke@hudsonsandler.com

 

About evoke Plc:

evoke plc (and together with its subsidiaries, "evoke" or the "Group") is one of the world's leading betting and gaming companies. The Group owns and operates internationally renowned brands including William Hill, 888, and Mr Green. Incorporated in Gibraltar, and headquartered and listed in London, the Group operates from offices around the world.

The Group's vision is to make life more interesting and its mission is to delight players with world-class betting and gaming experiences.

Find out more at: https://www.evokeplc.com

Further information:

Morgan Stanley & Co. International plc ("Morgan Stanley"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the PRA and the Financial Conduct Authority ("FCA") in the United Kingdom, is acting exclusively for evoke and for no one else in connection with the strategic review and neither Morgan Stanley nor any of its affiliates, nor their respective directors, officers, employees or agents will be responsible to anyone other than evoke for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement or any other matters referred to in this announcement.

The City Code on Takeovers and Mergers

The City Code on Takeovers and Mergers (the "Code") does not apply to the Company as it is registered in Gibraltar. As a result, a takeover offer for the Company will not be regulated by the UK Panel on Takeovers and Mergers (the "Panel"). The Company's articles of association contain certain takeover-related provisions, although these do not provide the full protections afforded by the Code and the enforcement of such provisions is the responsibility of the Company, not the Panel. Accordingly, shareholders of the Company are reminded that the Panel does not have responsibility, in relation to the Company, for ensuring compliance with the Code and is not able to answer shareholders' questions in that regard.

In particular, public disclosures consistent with the provisions of Rule 8 of the Code (as if it applied to the Company) should not be emailed to the Panel, but as described below, released directly through a Regulatory Information Service.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBBLFFELLEFBL
Date   Source Headline
12th Jun 20263:48 pmRNSAwards granted under the LTIP
9th Jun 20263:30 pmRNSNotification of Transactions by PDMR
8th Jun 202612:18 pmRNSResults of AGM 8 June 2026
5th Jun 20267:00 amRNSRecommended all-share acquisition of evoke plc
4th Jun 20265:55 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
18th May 20264:35 pmRNSExtension of Firm Offer Deadline
11th May 20267:00 amRNSPublication of Notice of AGM
1st May 20267:00 amRNSTotal Voting Rights & Correction
30th Apr 20267:00 amRNSFY25 Results
28th Apr 20262:11 pmRNSDelay to publication of FY25 audited results
20th Apr 20267:01 amRNSStatement regarding media speculation
14th Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 20269:56 amRNSTotal Voting Rights
31st Mar 202612:34 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSNotice of FY25 Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20267:00 amRNS2025 Post-close Trading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
18th Dec 20257:00 amRNSNotice of FY 2025 Trading Update
17th Dec 20254:40 pmRNSHolding(s) in Company
10th Dec 202510:53 amRNSStrategic Review
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20255:45 pmRNSResponse to the UK Budget
3rd Nov 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSQ3 2025 trading update
21st Oct 20257:00 amRNSBoard Change
14th Oct 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Oct 20257:00 amRNSCommittee Update
1st Oct 20257:00 amRNSTotal Voting Rights
25th Sep 20257:00 amRNSNotice of Q3 2025 trading update
11th Sep 20257:00 amRNSPricing of an offering of Senior Secured Notes
1st Sep 20257:00 amRNSTotal Voting Rights
13th Aug 20257:00 amRNSH1 2025 Interim Results
4th Aug 20257:00 amRNSInvestor Meet Company Presentation
1st Aug 20257:00 amRNSTotal Voting Rights
22nd Jul 20257:00 amRNSH1 2025 Post-Close Trading Update
16th Jul 20257:00 amRNSNotice of H1 2025 trading update
1st Jul 20257:00 amRNSTotal Voting Rights
26th Jun 20257:00 amRNSDirector Declaration
18th Jun 20258:28 amRNSDirector Declaration
2nd Jun 20257:00 amRNSTotal Voting Rights
28th May 202512:36 pmRNSResults of AGM 28 May 2025
28th May 20257:00 amRNSEstablishment of a Technology Committee
27th May 20255:39 pmRNSPurchase of Annual Bonus shares
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20255:53 pmRNSNotification of Transactions by PDMR
25th Apr 20258:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.